![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 4969 |
FusionGeneSummary for C3_ALB |
![]() |
Fusion gene information | Fusion gene name: C3_ALB | Fusion gene ID: 4969 | Hgene | Tgene | Gene symbol | C3 | ALB | Gene ID | 718 | 213 |
Gene name | complement C3 | albumin | |
Synonyms | AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p | HSA|PRO0883|PRO0903|PRO1341 | |
Cytomap | 19p13.3 | 4q13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | complement C3C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1C3a anaphylatoxinacylation-stimulating protein cleavage productcomplement component 3complement component C3acomplement component C3bepididymis secretory sperm binding pr | serum albumin | |
Modification date | 20180519 | 20180522 | |
UniProtAcc | P01024 | P02768 | |
Ensembl transtripts involved in fusion gene | ENST00000245907, ENST00000599668, | ENST00000295897, ENST00000415165, ENST00000503124, ENST00000509063, ENST00000401494, ENST00000505649, | |
Fusion gene scores | * DoF score | 20 X 13 X 8=2080 | 27 X 26 X 2=1404 |
# samples | 21 | 33 | |
** MAII score | log2(21/2080*10)=-3.30812229536233 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(33/1404*10)=-2.08900500605874 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: C3 [Title/Abstract] AND ALB [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | C3 | GO:0001934 | positive regulation of protein phosphorylation | 15833747 |
Hgene | C3 | GO:0010575 | positive regulation of vascular endothelial growth factor production | 16452172 |
Hgene | C3 | GO:0010828 | positive regulation of glucose transmembrane transport | 9059512|15833747 |
Hgene | C3 | GO:0010866 | regulation of triglyceride biosynthetic process | 10432298 |
Hgene | C3 | GO:0010884 | positive regulation of lipid storage | 9555951 |
Hgene | C3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 15833747 |
Tgene | ALB | GO:0009267 | cellular response to starvation | 16245148 |
Tgene | ALB | GO:0019836 | hemolysis by symbiont of host erythrocytes | 16394536 |
Tgene | ALB | GO:0043066 | negative regulation of apoptotic process | 16153637 |
Tgene | ALB | GO:0051659 | maintenance of mitochondrion location | 16153637 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AI305112 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-5UTR | ENST00000245907 | ENST00000295897 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-5UTR | ENST00000245907 | ENST00000415165 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-5UTR | ENST00000245907 | ENST00000503124 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-5UTR | ENST00000245907 | ENST00000509063 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-intron | ENST00000245907 | ENST00000401494 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-intron | ENST00000245907 | ENST00000505649 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-5UTR | ENST00000599668 | ENST00000295897 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-5UTR | ENST00000599668 | ENST00000415165 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-5UTR | ENST00000599668 | ENST00000503124 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-5UTR | ENST00000599668 | ENST00000509063 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-intron | ENST00000599668 | ENST00000401494 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
intron-intron | ENST00000599668 | ENST00000505649 | C3 | chr19 | 6682029 | + | ALB | chr4 | 74270017 | + |
Top |
FusionProtFeatures for C3_ALB |
![]() |
Hgene | Tgene |
C3 | ALB |
C3 plays a central role in the activation of thecomplement system. Its processing by C3 convertase is the centralreaction in both classical and alternative complement pathways.After activation C3b can bind covalently, via its reactivethioester, to cell surface carbohydrates or immune aggregates. Derived from proteolytic degradation of complement C3,C3a anaphylatoxin is a mediator of local inflammatory process. Inchronic inflammation, acts as a chemoattractant for neutrophils(By similarity). It induces the contraction of smooth muscle,increases vascular permeability and causes histamine release frommast cells and basophilic leukocytes. {ECO:0000250}. C3-beta-c: Acts as a chemoattractant for neutrophils inchronic inflammation. {ECO:0000250}. Acylation stimulating protein: adipogenic hormone thatstimulates triglyceride (TG) synthesis and glucose transport inadipocytes, regulating fat storage and playing a role inpostprandial TG clearance. Appears to stimulate TG synthesis viaactivation of the PLC, MAPK and AKT signaling pathways. Ligand forC5AR2. Promotes the phosphorylation, ARRB2-mediatedinternalization and recycling of C5AR2 (PubMed:8376604,PubMed:2909530, PubMed:9059512, PubMed:10432298, PubMed:15833747,PubMed:16333141, PubMed:19615750). {ECO:0000269|PubMed:10432298,ECO:0000269|PubMed:15833747, ECO:0000269|PubMed:16333141,ECO:0000269|PubMed:19615750, ECO:0000269|PubMed:2909530,ECO:0000269|PubMed:8376604, ECO:0000269|PubMed:9059512}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for C3_ALB |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for C3_ALB |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for C3_ALB |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | C3 | P01024 | DB01593 | Zinc | Complement C3 | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB00493 | Cefotaxime | Serum albumin | small molecule | approved |
Tgene | ALB | P02768 | DB01045 | Rifampicin | Serum albumin | small molecule | approved |
Tgene | ALB | P02768 | DB03255 | Phenol | Serum albumin | small molecule | approved|experimental |
Tgene | ALB | P02768 | DB00276 | Amsacrine | Serum albumin | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB00545 | Pyridostigmine | Serum albumin | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB06713 | Norelgestromin | Serum albumin | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB11638 | Artenimol | Serum albumin | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB00199 | Erythromycin | Serum albumin | small molecule | approved|investigational|vet_approved |
Top |
RelatedDiseases for C3_ALB |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | C3 | C0242383 | Age related macular degeneration | 4 | CTD_human |
Hgene | C3 | C2752037 | HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5 | 2 | ORPHANET;UNIPROT |
Hgene | C3 | C3151071 | COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE | 2 | ORPHANET;UNIPROT |
Hgene | C3 | C0007787 | Transient Ischemic Attack | 1 | CTD_human |
Hgene | C3 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Hgene | C3 | C0017665 | Membranous glomerulonephritis | 1 | CTD_human |
Hgene | C3 | C0021051 | Immunologic Deficiency Syndromes | 1 | CTD_human |
Hgene | C3 | C0021655 | Insulin Resistance | 1 | CTD_human |
Hgene | C3 | C0030524 | Paratuberculosis | 1 | CTD_human |
Hgene | C3 | C0030807 | Pemphigus | 1 | CTD_human |
Hgene | C3 | C0034152 | Henoch-Schoenlein Purpura | 1 | CTD_human |
Hgene | C3 | C0740392 | Infarction, Middle Cerebral Artery | 1 | CTD_human |
Hgene | C3 | C1969651 | Macular Degeneration, Age-Related, 9 | 1 | CTD_human;UNIPROT |
Hgene | C3 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | ALB | C0033687 | Proteinuria | 9 | CTD_human |
Tgene | ALB | C0017658 | Glomerulonephritis | 8 | CTD_human |
Tgene | ALB | C0022658 | Kidney Diseases | 8 | CTD_human |
Tgene | ALB | C0017665 | Membranous glomerulonephritis | 6 | CTD_human |
Tgene | ALB | C0027697 | Nephritis | 6 | CTD_human |
Tgene | ALB | C0027707 | Nephritis, Interstitial | 4 | CTD_human |
Tgene | ALB | C0038454 | Cerebrovascular accident | 4 | CTD_human |
Tgene | ALB | C0342185 | Hyperthyroxinemia, Familial Dysalbuminemic | 4 | CTD_human;UNIPROT |
Tgene | ALB | C0023893 | Liver Cirrhosis, Experimental | 3 | CTD_human |
Tgene | ALB | C0025290 | Aseptic Meningitis | 3 | CTD_human |
Tgene | ALB | C2609414 | Acute kidney injury | 3 | CTD_human |
Tgene | ALB | C0014544 | Epilepsy | 2 | CTD_human |
Tgene | ALB | C0020649 | Hypotension | 2 | CTD_human;HPO |
Tgene | ALB | C0023890 | Liver Cirrhosis | 2 | CTD_human |
Tgene | ALB | C0027726 | Nephrotic Syndrome | 2 | CTD_human |
Tgene | ALB | C0036830 | Serum Sickness | 2 | CTD_human |
Tgene | ALB | C0162557 | Liver Failure, Acute | 2 | CTD_human |
Tgene | ALB | C4277682 | Chemical and Drug Induced Liver Injury | 2 | CTD_human |
Tgene | ALB | C0002994 | Angioedema | 1 | CTD_human |
Tgene | ALB | C0003460 | Anuria | 1 | CTD_human |
Tgene | ALB | C0004509 | Azoospermia | 1 | CTD_human |
Tgene | ALB | C0006111 | Brain Diseases | 1 | CTD_human |
Tgene | ALB | C0007222 | Cardiovascular Diseases | 1 | CTD_human |
Tgene | ALB | C0007786 | Brain Ischemia | 1 | CTD_human |
Tgene | ALB | C0011581 | Depressive disorder | 1 | CTD_human |
Tgene | ALB | C0011875 | Diabetic Angiopathies | 1 | CTD_human |
Tgene | ALB | C0011881 | Diabetic Nephropathy | 1 | CTD_human |
Tgene | ALB | C0013502 | Echinococcosis | 1 | CTD_human |
Tgene | ALB | C0016059 | Fibrosis | 1 | CTD_human |
Tgene | ALB | C0017662 | Glomerulonephritis, Membranoproliferative | 1 | CTD_human |
Tgene | ALB | C0018799 | Heart Diseases | 1 | CTD_human |
Tgene | ALB | C0018801 | Heart failure | 1 | CTD_human |
Tgene | ALB | C0019061 | Hemolytic-Uremic Syndrome | 1 | CTD_human |
Tgene | ALB | C0019158 | Hepatitis | 1 | CTD_human |
Tgene | ALB | C0019693 | HIV Infections | 1 | CTD_human |
Tgene | ALB | C0019699 | HIV Seropositivity | 1 | CTD_human |
Tgene | ALB | C0020517 | Hypersensitivity | 1 | CTD_human |
Tgene | ALB | C0020522 | Delayed Hypersensitivity | 1 | CTD_human |
Tgene | ALB | C0020538 | Hypertensive disease | 1 | CTD_human |
Tgene | ALB | C0022548 | Keloid | 1 | CTD_human |
Tgene | ALB | C0022661 | Kidney Failure, Chronic | 1 | CTD_human |
Tgene | ALB | C0026848 | Myopathy | 1 | CTD_human |
Tgene | ALB | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human |
Tgene | ALB | C0027720 | Nephrosis | 1 | CTD_human |
Tgene | ALB | C0028797 | Occupational Diseases | 1 | CTD_human |
Tgene | ALB | C0030193 | Pain | 1 | CTD_human |
Tgene | ALB | C0030286 | Pancreatic Diseases | 1 | CTD_human |
Tgene | ALB | C0030305 | Pancreatitis | 1 | CTD_human |
Tgene | ALB | C0035222 | Respiratory Distress Syndrome, Adult | 1 | CTD_human |
Tgene | ALB | C0035242 | Respiratory Tract Diseases | 1 | CTD_human |
Tgene | ALB | C0035457 | Rhinitis, Allergic, Perennial | 1 | CTD_human |
Tgene | ALB | C0038325 | Stevens-Johnson Syndrome | 1 | CTD_human |
Tgene | ALB | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | ALB | C0040034 | Thrombocytopenia | 1 | CTD_human |
Tgene | ALB | C0041755 | Adverse reaction to drug | 1 | CTD_human |
Tgene | ALB | C0042109 | Urticaria | 1 | CTD_human |
Tgene | ALB | C0042164 | Uveitis | 1 | CTD_human |
Tgene | ALB | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Tgene | ALB | C0239981 | Hypoalbuminemia | 1 | CTD_human;HPO |
Tgene | ALB | C0993582 | Arthritis, Experimental | 1 | CTD_human |